n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabot, MC; Gupta, V; Jazwinski, SM; Liu, YY; Patwardhan, GA; Zhang, QJ | 1 |
| Babia, T; de Weerd, H; Hoekstra, D; Hulstaert, C; Kok, JW | 1 |
2 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and Colonic Neoplasms
| Article | Year |
|---|---|
Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Cell Line, Tumor; Cell Membrane Permeability; Ceramides; Chromatography, Thin Layer; Colonic Neoplasms; Enzyme Assays; Enzyme Inhibitors; Female; Glucosyltransferases; Glycosylation; Humans; Injections, Intralesional; Mice; Mice, Nude; Morpholines; Oligonucleotides; Ovarian Neoplasms; Random Allocation; Reproducibility of Results; Xenograft Model Antitumor Assays | 2010 |
Differential metabolism and trafficking of sphingolipids in differentiated versus undifferentiated HT29 cells.
Topics: 4-Chloro-7-nitrobenzofurazan; Adenocarcinoma; Cell Differentiation; Cell Membrane; Ceramides; Colonic Neoplasms; Glucosylceramides; Glycosphingolipids; Humans; Membrane Lipids; Neoplasm Proteins; Tumor Cells, Cultured | 1993 |